Sentences with phrase «discuss the results from»

At 4:30 p.m. Eastern Time today, Gilead's management will host a conference call and a simultaneous webcast to discuss results from its first quarter 2018 and a general business update.
They'll also discuss the results from some of the primary elections in New York and the significance of who won and who lost.
Sloan and Wolfendale also discussed the results from an experiment at CERN in Switzerland called CLOUD, where researchers are looking at ways in which cosmic rays can ionize, or charge, aerosols in the atmosphere, influencing how clouds are formed.
News 12 New Jersey, NewJersey.News12.com — June 15, 2017 Researcher Dr. Adana Llanos of Rutgers Cancer Institute of New Jersey and Rutgers School of Public Health discusses results from recent research that finds an association between breast cancer risk and use of some hair products.
WPIX TV Channel 11, PIX11.com — June 15, 2017 Researcher Dr. Adana Llanos of Rutgers Cancer Institute of New Jersey and Rutgers School of Public Health discusses results from recent research that finds an association between breast cancer risk and use of some hair products.
It also discusses the results from a small - scale randomized study of 62 4 - year - olds...
O'Brien discusses the results from the Programme for International Student Assessment (PISA) in regard to student performance in digital reading, navigation, and computer use — and what these results mean for educators in the United States.
We return below to discuss the results from a more scientific study of accountability.
Results are always substantively the same whether we use linear or logistic regressions, so we discuss results from the former because they are somewhat easier to interpret.
Join Kristin Shackelford, Evangelizer of the Business and Leadership solutions portfolio at Skillsoft, as she discusses the results from the survey and strategies that can help you develop effective and compelling modern learning programs.
As a matter of background, Sexton will also discuss the results from an earlier survey of all authors that show just how advanced hybrid authors are.
We'll discuss the results from any diagnostic testing we performed, and determine the next step in your pet's care, whether it's a follow up visit or a treatment plan.
In these webcast slides, our panel of in - house legal experts will discuss results from this legal spend study and provide specific insights into the spend management techniques employed at leading law departments, giving you new ideas to reduce legal spend at your organization without sacrificing quality.
In this on - demand webcast, our panel of in - house legal experts will discuss results from this legal spend study and provide specific insights into the spend management techniques employed at leading law departments, giving you new ideas to reduce legal spend at your organization without sacrificing quality.
Improved Child Welfare Services and Case Practice Needed in Prince George's: Child Advocates Identify Need for Significant Reforms (PDF - 203 KB) Advocates for Children and Youth (2010) Discusses results from interviews of people who represent or advocate for significant numbers of abused and neglected children.
And we discussed application of art play program based on character education and discussed result from it.

Not exact matches

Actual results or outcomes may differ materially from those implied by the forward - looking statements as a result of the impact of a number of factors, many of which are discussed in more detail in our Annual Report on Form 10 - K and our other reports filed with the Securities and Exchange Commission.
Charles Ragauss, director of product management at Exponential ETFs, discusses what to expect from Apple's results.
Actual results and the timing of events could differ materially from those anticipated in the forward - looking statements due to these risks and uncertainties as well as other factors, which include, without limitation: the uncertain timing of, and risks relating to, the executive search process; risks related to the potential failure of eptinezumab to demonstrate safety and efficacy in clinical testing; Alder's ability to conduct clinical trials and studies of eptinezumab sufficient to achieve a positive completion; the availability of data at the expected times; the clinical, therapeutic and commercial value of eptinezumab; risks and uncertainties related to regulatory application, review and approval processes and Alder's compliance with applicable legal and regulatory requirements; risks and uncertainties relating to the manufacture of eptinezumab; Alder's ability to obtain and protect intellectual property rights, and operate without infringing on the intellectual property rights of others; the uncertain timing and level of expenses associated with Alder's development and commercialization activities; the sufficiency of Alder's capital and other resources; market competition; changes in economic and business conditions; and other factors discussed under the caption «Risk Factors» in Alder's Annual Report on Form 10 - K for the fiscal year ended December 31, 2017, which was filed with the Securities and Exchange Commission (SEC) on February 26, 2018, and is available on the SEC's website at www.sec.gov.
Any of these risks and uncertainties may cause actual results to differ materially from the results discussed in the forward - looking statements.
The company refers you to the documents filed by the company from time to time with the SEC, specifically the section titled «Risk Factors» in the company's Annual Report on Form 10 - K for the year ended December 31, 2017, as may be updated or supplemented in the company's Quarterly Reports on Form 10 - Q and the company's other filings with the SEC, which discuss these and other factors that could adversely affect the company's results.
Actual results, including with respect to our targets and prospects, could differ materially due to a number of factors, including the risk that we may not obtain sufficient orders to achieve our targeted revenues; price competition in key markets; the risk that we or our channel partners are not able to develop and expand customer bases and accurately anticipate demand from end customers, which can result in increased inventory and reduced orders as we experience wide fluctuations in supply and demand; the risk that our commercial Lighting Products results will continue to suffer if new issues arise regarding issues related to product quality for this business; the risk that we may experience production difficulties that preclude us from shipping sufficient quantities to meet customer orders or that result in higher production costs and lower margins; our ability to lower costs; the risk that our results will suffer if we are unable to balance fluctuations in customer demand and capacity, including bringing on additional capacity on a timely basis to meet customer demand; the risk that longer manufacturing lead times may cause customers to fulfill their orders with a competitor's products instead; the risk that the economic and political uncertainty caused by the proposed tariffs by the United States on Chinese goods, and any corresponding Chinese tariffs in response, may negatively impact demand for our products; product mix; risks associated with the ramp - up of production of our new products, and our entry into new business channels different from those in which we have historically operated; the risk that customers do not maintain their favorable perception of our brand and products, resulting in lower demand for our products; the risk that our products fail to perform or fail to meet customer requirements or expectations, resulting in significant additional costs, including costs associated with warranty returns or the potential recall of our products; ongoing uncertainty in global economic conditions, infrastructure development or customer demand that could negatively affect product demand, collectability of receivables and other related matters as consumers and businesses may defer purchases or payments, or default on payments; risks resulting from the concentration of our business among few customers, including the risk that customers may reduce or cancel orders or fail to honor purchase commitments; the risk that we are not able to enter into acceptable contractual arrangements with the significant customers of the acquired Infineon RF Power business or otherwise not fully realize anticipated benefits of the transaction; the risk that retail customers may alter promotional pricing, increase promotion of a competitor's products over our products or reduce their inventory levels, all of which could negatively affect product demand; the risk that our investments may experience periods of significant stock price volatility causing us to recognize fair value losses on our investment; the risk posed by managing an increasingly complex supply chain that has the ability to supply a sufficient quantity of raw materials, subsystems and finished products with the required specifications and quality; the risk we may be required to record a significant charge to earnings if our goodwill or amortizable assets become impaired; risks relating to confidential information theft or misuse, including through cyber-attacks or cyber intrusion; our ability to complete development and commercialization of products under development, such as our pipeline of Wolfspeed products, improved LED chips, LED components, and LED lighting products risks related to our multi-year warranty periods for LED lighting products; risks associated with acquisitions, divestitures, joint ventures or investments generally; the rapid development of new technology and competing products that may impair demand or render our products obsolete; the potential lack of customer acceptance for our products; risks associated with ongoing litigation; and other factors discussed in our filings with the Securities and Exchange Commission (SEC), including our report on Form 10 - K for the fiscal year ended June 25, 2017, and subsequent reports filed with the SEC.
Actual results may differ materially from those indicated by these forward - looking statements as a result of various important factors including, but not limited to, the effects of any unexpected difficulty in closing our financial books for the quarter and other factors that are discussed in the Company's Annual Report on Form 10 - K, quarterly reports on Form 10 - Q, and other documents periodically filed with the SEC.
The result of these takeaways is Van Rooy's BSQ system, which borrows elements from the others discussed in this list.
There may be other factors of which Gilead is not currently aware that may affect matters discussed in the forward - looking statements and may also cause actual results to differ significantly from these estimates.
For employees with roles and responsibilities that benefit from cross-functional collaboration, meetings and team discussions allow employees to align project expectations, discuss progress toward goals and resolve inconsistencies in the work, resulting in outcomes that provide the competitive edge that organizations are looking for.
These forward - looking statements involve risks and uncertainties, and actual results could differ materially from those discussed.
«Windows 8 has been, from our standpoint, not necessarily the catalyst to drive accelerated growth that we thought it would be,» CFO Brian Gladden said on a conference call to discuss the results.
LONDON, April 11 Renewed caution among investors dented Britain's top share index on Wednesday as Western forces discussed possible military action against Syria, although strong results from Tesco pushed its shares higher.
No concrete results emerged from the meetings, though regional trade agreements were discussed.
Such risks and uncertainties include, but are not limited to: our ability to achieve our financial, strategic and operational plans or initiatives; our ability to predict and manage medical costs and price effectively and develop and maintain good relationships with physicians, hospitals and other health care providers; the impact of modifications to our operations and processes; our ability to identify potential strategic acquisitions or transactions and realize the expected benefits of such transactions, including with respect to the Merger; the substantial level of government regulation over our business and the potential effects of new laws or regulations or changes in existing laws or regulations; the outcome of litigation, regulatory audits, investigations, actions and / or guaranty fund assessments; uncertainties surrounding participation in government - sponsored programs such as Medicare; the effectiveness and security of our information technology and other business systems; unfavorable industry, economic or political conditions, including foreign currency movements; acts of war, terrorism, natural disasters or pandemics; our ability to obtain shareholder or regulatory approvals required for the Merger or the requirement to accept conditions that could reduce the anticipated benefits of the Merger as a condition to obtaining regulatory approvals; a longer time than anticipated to consummate the proposed Merger; problems regarding the successful integration of the businesses of Express Scripts and Cigna; unexpected costs regarding the proposed Merger; diversion of management's attention from ongoing business operations and opportunities during the pendency of the Merger; potential litigation associated with the proposed Merger; the ability to retain key personnel; the availability of financing, including relating to the proposed Merger; effects on the businesses as a result of uncertainty surrounding the proposed Merger; as well as more specific risks and uncertainties discussed in our most recent report on Form 10 - K and subsequent reports on Forms 10 - Q and 8 - K available on the Investor Relations section of www.cigna.com as well as on Express Scripts» most recent report on Form 10 - K and subsequent reports on Forms 10 - Q and 8 - K available on the Investor Relations section of www.express-scripts.com.
Those authorities may be changed, perhaps retroactively, or may be subject to differing interpretations, which could result in U.S. federal income tax consequences different from those discussed below.
Forward - looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those discussed in, or implied by, the forward - looking statements.
Investors who hold the fund within a tax - advantaged retirement account should consult their tax advisors to discuss tax consequences that could result if payments are distributed from their account prior to age 59 1/2 or if they plan to use the fund, in whole or in part, to meet their required minimum distribution (RMD) obligations.
In this webcast, John Sweeney and Richard Harris from DemandGen and James Ollerenshaw from Forrester will be discussing the reasons behind using buyer personas, the process of creating them for your organisation and some of the use cases and results.
The risk factors discussed in the «Risk Factors» section of PJT Partners» Information Statement, as filed with the Securities and Exchange Commission on September 2, 2015, as well as the other filings of PJT Partners with the Securities and Exchange Commission, could cause the results of PJT Partners to differ materially from those expressed in forward - looking statements.
As a result of this review, in early 2010 the HRC reduced base salaries from 2009 levels, as well as re-calibrated target and maximum payouts for annual incentive compensation (discussed below).
Our fiscal year underperformance relative to the S&P 500 can be explained by weak results in two of our portfolio holdings from late July through late August, when our portfolio underperformed by 4.47 % as both L Brands and NOW, Inc declined materially (discussed in more detail below).
Hardy went on to discuss the positive business - related implications that would result from shopping through a vcommerce environment.
«We have seen more promotional activity from our largest competitors in Ontario and the West than we have seen in the previous 12 months,» chief executive Michael Medline told analysts on a call to discuss results.
The results discussed in this news release are from drill core samples obtained by PQ and HQ - size triple - tube diamond core drilling using two PMC400 man - portable drill rigs owned by SAMJ and operated by Sumiko Resources Exploration & Development Co., Ltd. (a wholly owned exploration services subsidiary of Sumitomo Metal Mining Co., Ltd.) The drilling program was fully supervised by SAMJ senior project geologists at the drilling site.
As discussed in our Nov. 2008 Insight, deflation results when the overall supply of goods and services exceeds demand, and can result from supply leaping or from demand dropping.
The last he accepted as a result of his involvement in the terrors of the second world war (described in The Plague and The Rebel) and the other two when he had to face the possibility of death from tuberculosis (discussed in his earliest writings).
It makes no sense to discuss the differences from a moral standpoint, for in theory the differences are solely a result of human will and preference.
The guiding principle of British philosophy has in fact been that every difference must make a difference, every theoretical difference somewhere issue in a practical difference, and that the best method of discussing points of theory is to begin by ascertaining what practical difference would result from one alternative or the other being true.
He discusses the reproductive processes that result from the «directive capacity of DNA» and «believe [s]» that the idea that «blind and purposeless forces -LSB-...] spontaneously produce such a process is -LSB-...] metaphysically impossible» (our emphasis).
Of the two results that issue from the generalization of a mathematical formalism mentioned above, we will here discuss the possibility of unifying subordinate mathematical disciplines in a new formalism.
However, the dramatic difference from Rensch's determinism results only when this attribution is combined with the different view on whole - part relations discussed above.
RiceBran Technologies (NASDAQ: RIBT and RIBTW)(the «Company» or «RBT»), a global leader in the production and marketing of value added products derived from rice bran, announced today that Dr. Robert Smith, Interim Chief Executive Officer of RBT, will host a conference call on Thursday, November 10th at 4:30 p.m. EST to discuss the Company's financial results for the third quarter ended September 30, 2016.
SCOTTSDALE, Ariz. — May 11, 2016 — RiceBran Technologies (NASDAQ: RIBT and RIBTW)(the «Company» or «RBT»), a global leader in the production and marketing of value added products derived from rice bran, today announced that W. John Short, Chief Executive Officer & President of RBT, will host a conference call on Monday, May 16th at 4:30 p.m. EDT to discuss the Company's financial results for the first quarter ended March 31, 2016.
a b c d e f g h i j k l m n o p q r s t u v w x y z